Potassium%25252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCl) is an electrolyte supplement used to treat and prevent hypokalemia. ## Primary Indications * Treatment and prevention of hypokalemia. ## Adult Dosing Dosing is highly individualized based on serum potassium levels and clinical status. Local protocols should be consulted. * **Prevention of hypokalemia:** Typically 20 mEq (10 mmol) per day. * **Treatment of hypokalemia:** * Mild to moderate hypokalemia: 40-100 mEq (20-50 mmol) per day, divided into 2-5 doses. * Severe hypokalemia: May require higher doses, often administered intravenously under close cardiac monitoring. Maximum IV infusion rate is typically 10-20 mEq (5-10 mmol) per hour, not to exceed 40 mEq (20 mmol) per hour in critical care settings. Oral doses should not exceed 20 mEq (10 mmol) per dose. ## Pediatric Dosing Dosing is highly individualized based on serum potassium levels and clinical status. Local protocols should be consulted. * **Prevention of hypokalemia:** Typically 1-2 mEq/kg/day (1-2 mmol/kg/day), not to exceed adult maximums. * **Treatment of hypokalemia:** Up to 3-4 mEq/kg/day (3-4 mmol/kg/day), divided into doses. Maximum oral dose per dose is 20 mEq (10 mmol). Maximum IV infusion rate is typically 0.3-0.5 mEq/kg/hour (0.3-0.5 mmol/kg/hour), not to exceed 20 mEq/hour (10 mmol/hour). ## Dose Adjustments * **Renal Impairment:** Use with extreme caution. Dose reductions are necessary, and frequent monitoring of potassium levels is crucial. Severe renal impairment may preclude its use. * **Adrenal Insufficiency:** May lead to hyperkalemia. ## Contraindications * Hyperkalemia. * Conditions leading to sustained high potassium levels, such as untreated Addison's disease, severe renal impairment, and anuria. * Certain gastrointestinal conditions that impede passage, such as esophageal compression, gastric retention, peptic ulceration, and intestinal obstruction. ## Adverse Effects * **Common:** Nausea, vomiting, abdominal discomfort, diarrhea. * **Serious:** Hyperkalemia (can cause cardiac arrhythmias, muscle weakness, paralysis), gastrointestinal ulceration, bleeding, or perforation (especially with sustained-release formulations). ## Key Drug Interactions * **Potassium-sparing diuretics (e.g., spironolactone, amiloride), ACE inhibitors, ARBs, NSAIDs, trimethoprim, heparin:** Increased risk of hyperkalemia. * **Corticosteroids:** May increase potassium loss, potentially counteracting KCl therapy. * **Insulin:** Can shift potassium intracellularly, temporarily lowering serum potassium. * **Digoxin:** Hyperkalemia can increase digoxin toxicity. Hypokalemia increases digoxin toxicity. ## Monitoring * Serum potassium levels, especially during initiation, dose changes, and in patients with renal impairment. * Renal function (BUN, creatinine). * ECG for signs of hyperkalemia (peaked T waves, prolonged QRS). * Signs and symptoms of hypokalemia (weakness, fatigue, constipation, arrhythmias) and hyperkalemia (muscle weakness, paresthesias, cardiac changes). * Monitor for gastrointestinal side effects. ## Clinical Pearls * Oral potassium chloride can be irritating to the gastrointestinal tract; administer with food or fluids to minimize discomfort. * Sustained-release formulations may have a higher risk of gastrointestinal ulceration and should be used cautiously. * Intravenous potassium should always be diluted and administered via a peripheral or central line with appropriate monitoring. Never administer as a bolus. * Accurate assessment of potassium deficit is essential for appropriate dosing. *** *Disclaimer: This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines before making treatment decisions.*